Farfield Scientific Announces Pan-European Collaboration on Hepatitis Diagnostic Test

26-Nov-2007

Farfield Scientific has recently been awarded a prestigious contract as part of a pan-European research initiative to develop a diagnostic test for Hepatitis A, B and C. The project, code named SABIO, deploys one of the latest and most sensitive optical sensor technologies based on hollow or 'slot' waveguides to detect multiple analytes in sera, making it possible to test for these diseases in a single, label free, point of care assay. The collaboration between partners in Sweden, Austria, Spain, France, Belgium, Switzerland and Great Britain brings together a talented multidisciplinary team to diagnose one of the most common infectious diseases worldwide, second only to tuberculosis.

The identification and characterisation of suitable antibody interactions falls to the research group of Professor Heinz Zoller of the Hepatology Laboratory, Innsbruck Medical University, Austria, led by Professor Wolfgang Vogel.

"We look for viral infections and tumors. At present, routine diagnostic techniques must be performed in specialist laboratories." explains Professor Zoller. "Our first goal is detection of viral hepatitis, hepatocellular carcinoma and disturbances in iron metabolism."

Farfield's role has been to help quantify the coupling of these antigens to the waveguide surface using Farfield's patented Dual Polarisation Interferometry (DPI) technology, a technique which measures the quantity, structure and bioavailability of the captured antigens. Chemical and physical changes in the antigen are then tracked in real time such that the assay can be optimised.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures